189 related articles for article (PubMed ID: 36420774)
41. [New principles in tumor antigens and their significance in future immunotherapies for lymphomas and other malignancies--editorial].
Ke XY; Wang J; Yang XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):419-26. PubMed ID: 16800912
[TBL] [Abstract][Full Text] [Related]
42. Pediatric Cancer Immunotherapy: Opportunities and Challenges.
Wedekind MF; Denton NL; Chen CY; Cripe TP
Paediatr Drugs; 2018 Oct; 20(5):395-408. PubMed ID: 29948928
[TBL] [Abstract][Full Text] [Related]
43. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments.
Daver N; Alotaibi AS; Bücklein V; Subklewe M
Leukemia; 2021 Jul; 35(7):1843-1863. PubMed ID: 33953290
[TBL] [Abstract][Full Text] [Related]
44. Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.
Ceppi F; Beck-Popovic M; Bourquin JP; Renella R
Eur J Pediatr; 2017 Sep; 176(9):1163-1172. PubMed ID: 28803259
[TBL] [Abstract][Full Text] [Related]
45. Immunotherapy in pediatric malignancies: current status and future perspectives.
Capitini CM; Otto M; DeSantes KB; Sondel PM
Future Oncol; 2014; 10(9):1659-78. PubMed ID: 25145434
[TBL] [Abstract][Full Text] [Related]
46. Introduction to a review series on emerging immunotherapies for hematologic diseases.
Paczesny S; Pavletic SZ; Bollard CM
Blood; 2018 Jun; 131(24):2617-2620. PubMed ID: 29728405
[TBL] [Abstract][Full Text] [Related]
47. Immunotherapy for pediatric brain tumors: past and present.
Foster JB; Madsen PJ; Hegde M; Ahmed N; Cole KA; Maris JM; Resnick AC; Storm PB; Waanders AJ
Neuro Oncol; 2019 Oct; 21(10):1226-1238. PubMed ID: 31504801
[TBL] [Abstract][Full Text] [Related]
48. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.
Bareke H; Ibáñez-Navarro A; Guerra-García P; González Pérez C; Rubio-Aparicio P; Plaza López de Sabando D; Sastre-Urgelles A; Ortiz-Cruz EJ; Pérez-Martínez A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176035
[TBL] [Abstract][Full Text] [Related]
49. Cancer immunotherapies, their safety and toxicity.
Alatrash G; Jakher H; Stafford PD; Mittendorf EA
Expert Opin Drug Saf; 2013 Sep; 12(5):631-45. PubMed ID: 23668362
[TBL] [Abstract][Full Text] [Related]
50. Improving the clinical impact of biomaterials in cancer immunotherapy.
Gammon JM; Dold NM; Jewell CM
Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
[TBL] [Abstract][Full Text] [Related]
51. Application of CAR T cells for the treatment of solid tumors.
Khan JF; Khan AS; Brentjens RJ
Prog Mol Biol Transl Sci; 2019; 164():293-327. PubMed ID: 31383408
[TBL] [Abstract][Full Text] [Related]
52. [New directions in immunotherapy for malignant solid tumors].
Okuno K; Sugiura F; Sukegawa Y; Inoue K
Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
[TBL] [Abstract][Full Text] [Related]
53. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
Pennock GK; Chow LQ
Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
[TBL] [Abstract][Full Text] [Related]
54. Advancing cellular immunotherapy with macrophages.
Mishra AK; Malonia SK
Life Sci; 2023 Sep; 328():121857. PubMed ID: 37307965
[TBL] [Abstract][Full Text] [Related]
55. The evolving landscape of immunotherapy in solid tumors.
Keilson JM; Knochelmann HM; Paulos CM; Kudchadkar RR; Lowe MC
J Surg Oncol; 2021 Mar; 123(3):798-806. PubMed ID: 33595890
[TBL] [Abstract][Full Text] [Related]
56. Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress.
Chergui A; Reagan JL
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627165
[TBL] [Abstract][Full Text] [Related]
57. Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.
Foster JB; Alonso MM; Sayour E; Davidson TB; Persson ML; Dun MD; Kline C; Mueller S; Vitanza NA; van der Lugt J
Neoplasia; 2023 Aug; 42():100909. PubMed ID: 37244226
[TBL] [Abstract][Full Text] [Related]
58. Optimizing tumor immune response through combination of radiation and immunotherapy.
El Chediak A; Shamseddine A; Bodgi L; Obeid JP; Geara F; Zeidan YH
Med Oncol; 2017 Aug; 34(9):165. PubMed ID: 28828581
[TBL] [Abstract][Full Text] [Related]
59. Immunotherapy for solid tumors--a review for surgeons.
Saied A; Pillarisetty VG; Katz SC
J Surg Res; 2014 Apr; 187(2):525-35. PubMed ID: 24485876
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic Advances in Immunotherapies for Hematological Malignancies.
Nogami A; Sasaki K
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
